A detailed history of Walleye Trading LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Walleye Trading LLC holds 2,000 shares of NBIX stock, worth $273,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Holding current value
$273,000
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.58 - $153.15 $50,300 - $67,232
439 New
439 $50,000
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $5,216 - $5,749
40 New
40 $5,000
Q2 2022

Aug 08, 2022

SELL
$75.79 - $100.07 $494,075 - $652,356
-6,519 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$72.45 - $94.81 $331,313 - $433,566
4,573 Added 234.99%
6,519 $611,000
Q4 2021

Feb 14, 2022

BUY
$79.65 - $106.22 $119,395 - $159,223
1,499 Added 335.35%
1,946 $166,000
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $203,901 - $234,304
-2,366 Reduced 84.11%
447 $43,000
Q2 2021

Aug 16, 2021

SELL
$89.43 - $102.27 $40,601 - $46,430
-454 Reduced 13.9%
2,813 $274,000
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $172,863 - $235,695
1,974 Added 152.67%
3,267 $318,000
Q4 2020

Feb 16, 2021

SELL
$86.91 - $108.33 $406,999 - $507,309
-4,683 Reduced 78.36%
1,293 $124,000
Q3 2020

Nov 16, 2020

SELL
$96.16 - $135.15 $2.53 Million - $3.55 Million
-26,286 Reduced 81.48%
5,976 $575,000
Q1 2020

May 15, 2020

BUY
$75.11 - $113.76 $2.36 Million - $3.58 Million
31,468 Added 3963.22%
32,262 $2.79 Million
Q4 2019

Feb 14, 2020

SELL
$86.8 - $118.57 $1.09 Million - $1.49 Million
-12,606 Reduced 94.07%
794 $85,000
Q4 2018

Feb 14, 2019

BUY
$68.32 - $124.36 $832,069 - $1.51 Million
12,179 Added 997.46%
13,400 $957,000
Q3 2018

Nov 14, 2018

BUY
$98.88 - $125.85 $120,732 - $153,662
1,221 New
1,221 $150,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.